These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 1460860

  • 1. Mechanisms of cancer-induced hypercalcemia.
    Rosol TJ, Capen CC.
    Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
    [Abstract] [Full Text] [Related]

  • 2. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA.
    Cancer Res; 1997 Aug 01; 57(15):3194-9. PubMed ID: 9242449
    [Abstract] [Full Text] [Related]

  • 4. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ, Broadus AE.
    Annu Rev Med; 1994 Aug 01; 45():189-200. PubMed ID: 8198376
    [Abstract] [Full Text] [Related]

  • 5. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
    Insogna KL.
    Endocrinol Metab Clin North Am; 1989 Sep 01; 18(3):779-94. PubMed ID: 2673773
    [Abstract] [Full Text] [Related]

  • 6. Hypercalcemia and bone resorption in malignancy.
    Walls J, Bundred N, Howell A.
    Clin Orthop Relat Res; 1995 Mar 01; (312):51-63. PubMed ID: 7634618
    [Abstract] [Full Text] [Related]

  • 7. Hypercalcemia of malignancy--new insights into an old syndrome.
    Esbrit P.
    Clin Lab; 2001 Mar 01; 47(1-2):67-71. PubMed ID: 11214225
    [Abstract] [Full Text] [Related]

  • 8. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy.
    Chattopadhyay N.
    Am J Physiol Endocrinol Metab; 2006 May 01; 290(5):E761-70. PubMed ID: 16603723
    [Abstract] [Full Text] [Related]

  • 9. [Malignancy-associated hypercalcemia].
    Yamaguchi K.
    Gan To Kagaku Ryoho; 1991 Mar 01; 18(3):343-9. PubMed ID: 2003737
    [Abstract] [Full Text] [Related]

  • 10. Hypercalcemia of malignancy: a review of advances in pathophysiology.
    Kaplan M.
    Oncol Nurs Forum; 1994 Jul 01; 21(6):1039-46; quiz 1047-8. PubMed ID: 7971410
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO, Anderson DM, Traianedes K, Williams PJ, Yoneda T, Mundy GR.
    Cancer Res; 2001 Mar 15; 61(6):2572-8. PubMed ID: 11289133
    [Abstract] [Full Text] [Related]

  • 12. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia].
    Okazaki R.
    Clin Calcium; 2010 Oct 15; 20(10):1497-502. PubMed ID: 20890031
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA.
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec 15; 18(6):339-46. PubMed ID: 21897221
    [Abstract] [Full Text] [Related]

  • 14. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA, Guise TA.
    Endocr Relat Cancer; 2005 Sep 15; 12(3):549-83. PubMed ID: 16172192
    [Abstract] [Full Text] [Related]

  • 15. Hypercalcemia of cancer: an update.
    Goni MH, Tolis G.
    Anticancer Res; 1993 Sep 15; 13(4):1155-60. PubMed ID: 8352538
    [Abstract] [Full Text] [Related]

  • 16. [Hypercalcemia and neoplasms: recent advances in pathogenesis].
    Virgolini L, Gallizia C.
    Recenti Prog Med; 1990 Oct 15; 81(10):635-41. PubMed ID: 2291007
    [Abstract] [Full Text] [Related]

  • 17. Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy.
    Ralston SH, Boyce BF, Cowan RA, Gardner MD, Fraser WD, Boyle IT.
    J Bone Miner Res; 1989 Feb 15; 4(1):103-11. PubMed ID: 2718773
    [Abstract] [Full Text] [Related]

  • 18. [The pathogenesis of the humoral hypercalcemia syndrome in patients with solid tumors].
    Naafs MA, Silberbusch J.
    Ned Tijdschr Geneeskd; 1989 May 27; 133(21):1065-9. PubMed ID: 2662028
    [No Abstract] [Full Text] [Related]

  • 19. [Hypercalcemia in malignancy].
    Eto S.
    Rinsho Byori; 1994 Sep 27; 42(9):943-51. PubMed ID: 7967119
    [Abstract] [Full Text] [Related]

  • 20. Paraneoplastic syndrome of hypercalcemia and leukocytosis caused by squamous carcinoma cells (T3M-1) producing parathyroid hormone-related protein, interleukin 1 alpha, and granulocyte colony-stimulating factor.
    Sato K, Fujii Y, Kakiuchi T, Kasono K, Imamura H, Kondo Y, Mano H, Okabe T, Asano S, Takaku F.
    Cancer Res; 1989 Sep 01; 49(17):4740-6. PubMed ID: 2474371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.